AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2012
Jul 5, 2012
31542_dirs_2012-07-05_a84fa118-7ebf-4e74-acd3-b8f3123592dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2012-07-03
Reporting Person: Miller Steve (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-03 | Common Stock, par value $0.001 per share | P | 12300 | $0.546 | Acquired | 87054 | Direct |
| 2012-07-03 | Common Stock, par value $0.001 per share | P | 27700 | $0.55 | Acquired | 114754 | Direct |
More from CATALYST PHARMACEUTICALS, INC.
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6